These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 11812256)
1. Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia. Ito C Curr Pharm Des; 2002; 8(2):147-53. PubMed ID: 11812256 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of amphetamine and phencyclidine on the expression of growth-associated protein GAP-43. Vukosavic S; Ruzdijic S; Veskov R; Rakic L; Kanazir S Neurosci Res; 2001 Jun; 40(2):133-40. PubMed ID: 11377751 [TBL] [Abstract][Full Text] [Related]
3. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Steinpreis RE Behav Brain Res; 1996 Jan; 74(1-2):45-55. PubMed ID: 8851914 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. Ballmaier M; Bortolato M; Rizzetti C; Zoli M; Gessa G; Heinz A; Spano P Neuropsychopharmacology; 2007 Oct; 32(10):2098-107. PubMed ID: 17299506 [TBL] [Abstract][Full Text] [Related]
9. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. Snyder SH Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465 [No Abstract] [Full Text] [Related]
10. Clinical Therapeutic Conference: dopaminergic/serotonergic actions of phencyclidine as a model for schizophreniform psychosis. Gabbert JF; Giannini AJ Am J Ther; 1997 Apr; 4(4):159-63. PubMed ID: 10423606 [No Abstract] [Full Text] [Related]
11. Antipsychotic pathway genes with expression altered in opposite direction by antipsychotics and amphetamine. Ko F; Tallerico T; Seeman P Synapse; 2006 Aug; 60(2):141-51. PubMed ID: 16715494 [TBL] [Abstract][Full Text] [Related]
12. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Yui K; Goto K; Ikemoto S; Ishiguro T; Angrist B; Duncan GE; Sheitman BB; Lieberman JA; Bracha SH; Ali SF Mol Psychiatry; 1999 Nov; 4(6):512-23. PubMed ID: 10578232 [TBL] [Abstract][Full Text] [Related]
13. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Javitt DC Hillside J Clin Psychiatry; 1987; 9(1):12-35. PubMed ID: 2820854 [TBL] [Abstract][Full Text] [Related]
14. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia. Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment. Marksteiner J; Weiss U; Weis C; Laslop A; Fischer-Colbrie R; Humpel C; Feldon J; Fleischhacker WW Neuroscience; 2001; 104(2):325-33. PubMed ID: 11377837 [TBL] [Abstract][Full Text] [Related]
17. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine. Sams-Dodd F Neuropsychopharmacology; 1998 Apr; 18(4):293-304. PubMed ID: 9509497 [TBL] [Abstract][Full Text] [Related]
18. Catecholamines in the brain as mediators of amphetamine psychosis. Snyder SH Arch Gen Psychiatry; 1972 Aug; 27(2):169-79. PubMed ID: 4339577 [No Abstract] [Full Text] [Related]
19. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study. Rosse RB; Collins JP; Fay-McCarthy M; Alim TN; Wyatt RJ; Deutsch SI Clin Neuropharmacol; 1994 Aug; 17(4):359-69. PubMed ID: 9316684 [TBL] [Abstract][Full Text] [Related]
20. A review of NMDA receptors and the phencyclidine model of schizophrenia. Thornberg SA; Saklad SR Pharmacotherapy; 1996; 16(1):82-93. PubMed ID: 8700797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]